Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 14Lymphoid 7Thoracic 1

Conditions

Hepatitis B 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
entecavir × Thoracic × Clear all
NCT03680183 2018-09-28

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡